Skip to content
Insider tapeFilings through Fri, Nov 13
My stocks

InMed Pharmaceuticals (MTRI) insider trading

Insider activity, historical context and SEC filings · data through Nov 13, 2026

Health CareBiotechnologyMTRI

Closing price · Nov 13, 2026 $18.60 +1.4% on the day · +2.8% over 12 months 52-week range $6.15 – $18.60
Get MTRI alerts
Open-market purchases1 insider$35K · last 12 months
Insiders selling0last 12 months
Reported sales$0last 12 months
In 15 seconds

Insiders put their own money in: $35K of open-market buys. See how similar setups did below.

Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Purchase Adar1 Capital Management, LLC, 10% Owner bought 2,640 shares at $13.10 ($35K).

Trade date
Nov 5, 2026
Disclosed to the SEC
Nov 9, 2026
Type
Open-market purchase (code P)

Adar1 Capital Management, LLC's record since 2026: 1 of 1 past buy beat the S&P 500 over 90 days (small sample).

Read the original SEC filing ↗All MTRI insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

MTRI insider transactions (Form 4)

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Nov 9SEC Adar1 Capital Management, LLC10% OwnerFirst buy Buy 2,64098,297 held (+3%) $13.10 $35K +42.0% 80

Play with MTRI in the Research Lab

Pre-set to MTRI's latest insider buy of $10K or more (Nov 9, 2026: Adar1 Capital Management, LLC, $35K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 16,899 past insider buys did.

Open the full Backtester →

Share price and insider trades

MTRI closeInsider buyInsider sale
5101520DecJan 2026FebMarAprMayJunJulAugSepOctNovBought $34,572 on 2026-11-05 · Adar1 Capital Management, LLC
Bought, 12 months$35K
Sold, 12 months$0
Insiders buying1
Insiders selling0

InMed Pharmaceuticals insider trading at a glance (Nov 13, 2026): in the past 12 months, 1 insider bought $35K and 0 sold $0 of MTRI stock on the open market.

Setup Odds: how past setups like this did

MTRI's latest insider buying (Nov 9, 2026) matched against every similar buy since 2020.

How it works →

1 insider buying no CEO or CFO under $250K stock up over 3 months

1303 of 2821 past setups like this beat the S&P 500 over the next 90 days (46%), against 46% for all insider buys.

46 of 100 similar setups beat the S&P 500beat didn't
−40%−20%0% = S&P+20%+40%
How those 2,821 cases did vs. the S&P 500 over 90 days. Hover a bar for counts.
Outcome Cloud each dot is one of these 2,821 past setups (400 shown); the white ring is MTRI's buy, result due in 90 days
Beat the S&P 500 ↑Lagged ↓-50%-25%+0%+25%+50%2020202120222023202420252026OVLY 2021-01-27: +16% vs S&P +12%KMI 2024-11-06: +5% vs S&P +2%LCFY 2026-04-07: -32% vs S&P +14%RXST 2021-11-18: +7% vs S&P -5%GF 2020-08-13: +2% vs S&P +6%OTLK 2024-03-29: -28% vs S&P +5%MGPI 2020-11-09: +60% vs S&P +10%FIS 2024-07-16: +15% vs S&P +4%CASY 2026-06-29: -23% vs S&P +4%BKGM 2021-09-30: -6% vs S&P +12%HBB 2021-05-12: -27% vs S&P +10%ABR 2024-06-12: +2% vs S&P +2%GAM 2026-02-04: +5% vs S&P +6%NHC 2026-06-02: +18% vs S&P +1%MNSB 2023-02-07: -30% vs S&P -0%BWB 2023-08-29: +0% vs S&P +2%JOF 2025-09-19: +3% vs S&P +2%NMZ 2023-08-10: -10% vs S&P -2%BFST 2022-08-05: -0% vs S&P -10%GME 2025-07-01: +15% vs S&P +8%RSF 2025-05-29: +2% vs S&P +10%MKL 2021-05-07: +2% vs S&P +5%CLBK 2022-11-01: -5% vs S&P +5%FKYS 2021-11-19: +1% vs S&P -6%FNLC 2026-05-01: +22% vs S&P +3%HGTY 2025-09-08: +4% vs S&P +6%PCB 2022-02-02: -6% vs S&P -9%NREF 2021-03-22: +13% vs S&P +6%ISD 2023-08-14: -4% vs S&P -1%GSBD 2020-12-03: +1% vs S&P +4%CCNE 2024-07-23: -7% vs S&P +6%BCSF 2025-03-17: -7% vs S&P +6%JOF 2024-12-11: +7% vs S&P -8%NVOS 2022-04-21: -11% vs S&P -9%RMBI 2026-06-01: +13% vs S&P +2%MCD 2025-02-14: +3% vs S&P -3%BWFG 2024-07-31: +3% vs S&P +6%DCI 2023-04-12: -1% vs S&P +9%BSTZ 2020-12-23: -9% vs S&P +6%CAC 2021-02-08: +19% vs S&P +8%GDL 2021-02-18: +1% vs S&P +6%BHB 2024-05-30: +25% vs S&P +7%AXSM 2025-09-09: +17% vs S&P +5%KRP 2021-01-25: +17% vs S&P +9%NEN 2022-09-22: -9% vs S&P +4%PVH 2025-06-12: +27% vs S&P +8%NMCO 2026-02-19: +1% vs S&P +9%AWF 2024-01-05: +6% vs S&P +10%LIQT 2021-04-27: -26% vs S&P +6%RRBI 2026-02-04: -1% vs S&P +6%CARS 2021-03-01: +3% vs S&P +8%BDSX 2023-08-23: -24% vs S&P +3%RMT 2020-01-09: -30% vs S&P -16%NWFL 2024-09-11: +14% vs S&P +9%RRBI 2021-11-05: -3% vs S&P -4%WSBC 2022-09-15: +5% vs S&P +3%LCRDX 2021-07-19: +4% vs S&P +5%PML 2024-01-26: +1% vs S&P +4%CRF 2021-02-25: -9% vs S&P +10%BSTZ 2024-01-24: +4% vs S&P +4%KO 2020-02-07: -24% vs S&P -13%AIG 2024-11-26: +4% vs S&P -0%FRAF 2025-03-07: -1% vs S&P +3%NKSH 2020-10-29: +22% vs S&P +14%RRBI 2025-02-06: -8% vs S&P -7%FKYS 2020-06-29: -0% vs S&P +8%PKOH 2025-11-13: +37% vs S&P +3%ARCC 2020-06-15: -3% vs S&P +9%BCAT 2023-02-02: +1% vs S&P -2%MRVL 2024-06-24: +9% vs S&P +5%FUNC 2021-12-23: +22% vs S&P -5%PRU 2020-08-13: +7% vs S&P +6%NVG 2024-11-07: +2% vs S&P +2%ETO 2023-08-16: -1% vs S&P +2%GLQ 2023-08-09: -7% vs S&P -2%OPAL 2022-08-31: -16% vs S&P +0%CNOB 2026-06-16: -2% vs S&P +2%NXG 2024-09-10: +27% vs S&P +11%AUB 2024-03-11: -8% vs S&P +5%NZF 2025-08-21: +9% vs S&P +5%PCG 2025-11-05: -5% vs S&P +2%MSGE 2024-08-22: -13% vs S&P +6%RMBI 2024-02-09: +8% vs S&P +4%MXF 2026-02-02: +1% vs S&P +4%AMPG 2021-12-30: -17% vs S&P -3%RFIL 2024-10-04: -7% vs S&P +2%HTD 2026-01-27: +5% vs S&P +3%CMT 2022-03-11: -3% vs S&P -4%BHB 2026-03-03: +7% vs S&P +12%NBTB 2023-12-14: -17% vs S&P +10%CTO 2020-08-05: +16% vs S&P +2%MARA 2022-08-25: -50% vs S&P -4%OHI 2021-04-01: -4% vs S&P +7%PETS 2025-01-10: -34% vs S&P -9%ALTO 2021-12-09: +22% vs S&P -8%CBKM 2021-11-05: +7% vs S&P -4%ROOT 2023-11-15: -18% vs S&P +10%NEA 2024-08-22: +2% vs S&P +6%BCSF 2022-03-25: -13% vs S&P -16%NWPP 2026-02-17: +4% vs S&P +8%DSM 2025-12-02: +6% vs S&P +1%MX 2020-06-04: +13% vs S&P +15%BRO 2021-07-29: +14% vs S&P +3%PEBO 2022-08-08: -0% vs S&P -8%MSBI 2023-01-12: -25% vs S&P +3%BSBK 2022-02-11: +4% vs S&P -11%CVBF 2023-08-25: +4% vs S&P +4%EML 2020-11-20: +19% vs S&P +10%BDL 2021-06-14: -31% vs S&P +5%INSP 2024-01-24: +12% vs S&P +4%GHY 2023-12-07: +5% vs S&P +12%ARR 2021-03-22: -6% vs S&P +6%OPP 2020-11-20: +8% vs S&P +10%FINW 2023-08-16: +1% vs S&P +2%LMB 2022-11-22: +24% vs S&P +2%EMD 2025-05-28: +10% vs S&P +10%BY 2024-08-08: +24% vs S&P +12%NAGRX 2024-08-05: +3% vs S&P +11%CSPI 2022-06-13: -12% vs S&P +9%APO 2023-11-07: +23% vs S&P +13%DLHC 2020-06-16: +2% vs S&P +9%CME 2024-09-27: +10% vs S&P +6%ECG 2025-12-08: +21% vs S&P -1%ISTR 2021-07-29: -16% vs S&P +3%KVHI 2025-11-17: +19% vs S&P +3%TAP 2025-05-09: -9% vs S&P +12%ENR 2020-08-18: -6% vs S&P +8%FRST 2023-09-06: +25% vs S&P +3%ASTS 2025-12-17: +55% vs S&P +0%IOR 2025-06-05: -1% vs S&P +9%MSEX 2026-02-27: -3% vs S&P +10%F 2021-02-25: +18% vs S&P +10%CMTV 2024-12-13: +3% vs S&P -8%REPX 2023-04-20: -21% vs S&P +11%DPG 2026-02-10: +6% vs S&P +7%PUMP 2020-08-25: -0% vs S&P +4%SEZL 2024-12-06: -38% vs S&P -5%BANF 2022-10-19: -3% vs S&P +8%ACP 2021-11-01: -9% vs S&P -4%CINF 2021-08-11: +3% vs S&P +6%BSBK 2024-08-05: +17% vs S&P +11%RVT 2021-02-26: +9% vs S&P +11%FGBI 2021-06-30: +3% vs S&P +2%DSGR 2024-06-10: +12% vs S&P +1%CPZ 2025-01-10: -1% vs S&P -9%GUG 2024-09-03: +2% vs S&P +10%CORT 2020-12-02: +8% vs S&P +6%FERLX 2026-06-11: +2% vs S&P +4%ORI 2023-08-02: -0% vs S&P -7%GH 2023-06-13: -11% vs S&P +3%EBF 2025-07-29: -7% vs S&P +8%NECB 2023-03-10: -6% vs S&P +12%ELAN 2021-11-17: -19% vs S&P -4%CAT 2021-05-06: -13% vs S&P +5%DMRC 2023-05-19: +9% vs S&P +5%SENEA 2021-07-06: -3% vs S&P -1%KEYS 2025-06-02: +3% vs S&P +9%RM 2025-02-19: -22% vs S&P -3%BHB 2025-11-03: +16% vs S&P +2%AXR 2021-04-14: +13% vs S&P +6%OWSCX 2021-06-08: +3% vs S&P +8%LODE 2023-11-09: +0% vs S&P +15%PINE 2020-10-30: +15% vs S&P +16%FRPH 2026-02-19: -5% vs S&P +9%RMT 2020-10-13: +29% vs S&P +9%SBH 2025-09-08: +6% vs S&P +6%ATO 2020-06-12: -6% vs S&P +10%FOF 2022-08-12: -10% vs S&P -7%CTBI 2023-11-02: +8% vs S&P +13%CVEO 2020-07-08: +25% vs S&P +6%DMLP 2021-12-20: +29% vs S&P -2%PRAX 2023-10-10: +48% vs S&P +10%CLST 2025-10-30: +15% vs S&P +3%ALTG 2021-06-11: -2% vs S&P +6%EAD 2021-02-05: +8% vs S&P +8%DGICA 2021-08-11: -5% vs S&P +6%DXPE 2020-06-10: -3% vs S&P +5%NXG 2025-11-05: +4% vs S&P +2%SFST 2021-12-23: -17% vs S&P -5%PKOH 2023-08-14: +28% vs S&P -1%RBCAA 2025-06-04: +12% vs S&P +8%PSTL 2022-08-08: -2% vs S&P -8%PBHC 2020-08-25: +17% vs S&P +4%CHMG 2021-02-01: +26% vs S&P +11%PMT 2026-01-27: -7% vs S&P +3%BCBP 2020-12-07: +40% vs S&P +4%PRIVX 2026-01-14: +1% vs S&P +1%RYAN 2025-05-13: -13% vs S&P +9%FNB 2020-07-24: +5% vs S&P +8%IBKR 2025-02-04: -19% vs S&P -6%CRMD 2024-12-13: +24% vs S&P -8%CBU 2023-08-18: -7% vs S&P +4%GGROU 2022-07-06: -20% vs S&P -1%PCB 2021-12-14: +9% vs S&P -10%CCFN 2025-08-06: +7% vs S&P +7%APO 2021-09-09: +17% vs S&P +5%RYAM 2022-11-17: -8% vs S&P +5%CF 2020-11-25: +23% vs S&P +7%GRF 2025-11-19: +9% vs S&P +3%NWFL 2025-10-28: +6% vs S&P +1%MBLY 2024-11-06: +3% vs S&P +2%ASMB 2024-10-09: +9% vs S&P +2%ESOA 2024-03-21: -6% vs S&P +5%EVER 2021-03-01: -36% vs S&P +8%OXM 2022-01-04: -8% vs S&P -4%FNB 2022-02-03: -6% vs S&P -4%SLNG 2021-06-24: -37% vs S&P +3%ILPT 2021-08-05: +6% vs S&P +6%RCL 2023-08-14: -9% vs S&P -1%CZFS 2026-03-06: +5% vs S&P +13%PCB 2020-11-13: +21% vs S&P +10%EMYB 2024-08-22: +9% vs S&P +6%GPN 2026-02-23: -8% vs S&P +10%CTRN 2026-03-26: +48% vs S&P +14%NXDT 2024-10-09: -0% vs S&P +2%CION 2024-05-17: +1% vs S&P +5%CCNE 2025-08-13: +2% vs S&P +6%QRHC 2023-08-17: -2% vs S&P +3%CODI 2023-03-23: +18% vs S&P +11%KROS 2023-01-20: -11% vs S&P +4%MDLZ 2021-11-09: +9% vs S&P -4%GHC 2024-05-29: +8% vs S&P +7%HQL 2020-05-22: +2% vs S&P +15%NAD 2024-07-02: +7% vs S&P +5%CNOB 2023-11-20: +6% vs S&P +10%FKYS 2025-05-30: +19% vs S&P +10%FFIN 2026-06-15: -1% vs S&P +2%ISTR 2021-01-26: +30% vs S&P +9%KDP 2022-03-01: -7% vs S&P -3%CRWS 2023-12-08: +13% vs S&P +12%DTM 2022-02-10: -0% vs S&P -12%RIG 2022-11-14: +66% vs S&P +4%AMZN 2020-07-02: +9% vs S&P +8%FDBC 2020-08-27: +32% vs S&P +5%MTX 2023-03-08: -7% vs S&P +8%BATL 2021-06-15: -41% vs S&P +6%NRIM 2022-09-08: +34% vs S&P -1%BMEA 2023-02-10: +219% vs S&P +1%GMED 2020-06-24: +12% vs S&P +9%AON 2022-08-25: +5% vs S&P -4%CAT 2025-11-06: +22% vs S&P +3%COFS 2022-12-05: +20% vs S&P +2%GRX 2023-12-13: +10% vs S&P +10%BOTJ 2021-10-27: -1% vs S&P -4%COFS 2026-02-17: +8% vs S&P +8%JHI 2026-01-27: -1% vs S&P +3%BCBP 2026-03-02: +30% vs S&P +11%KINS 2020-08-13: +6% vs S&P +6%GLO 2025-09-05: +5% vs S&P +6%CHCO 2021-01-25: +9% vs S&P +9%DMLP 2021-11-08: +27% vs S&P -4%GLIBK 2026-03-04: -45% vs S&P +11%RM 2020-08-17: +32% vs S&P +6%BLNK 2020-06-26: +155% vs S&P +8%CHD 2024-12-17: +4% vs S&P -6%NRIM 2022-03-01: -3% vs S&P -3%OMEX 2021-03-22: -6% vs S&P +6%SACH 2021-11-16: -17% vs S&P -6%HOG 2022-08-10: +17% vs S&P -9%AFL 2020-08-18: +16% vs S&P +8%PEBO 2021-11-10: +2% vs S&P -2%HOG 2023-08-02: -29% vs S&P -7%HPK 2021-12-02: +55% vs S&P -4%PRKA 2021-06-08: -14% vs S&P +8%RAND 2022-12-07: -2% vs S&P +2%NEWT 2025-08-04: -7% vs S&P +8%ORRF 2025-09-04: +6% vs S&P +6%MVBF 2023-08-22: -18% vs S&P +4%CLFD 2021-02-11: -5% vs S&P +4%ESOA 2025-05-20: -10% vs S&P +9%JBL 2021-12-22: -10% vs S&P -4%RVSB 2023-09-07: +7% vs S&P +3%GCV 2025-11-19: +14% vs S&P +3%GLO 2025-08-13: +8% vs S&P +6%OSBC 2020-12-14: +31% vs S&P +9%JFR 2023-12-15: +9% vs S&P +10%NTRP 2025-11-06: -26% vs S&P +3%APLE 2021-03-17: +2% vs S&P +7%FNB 2020-12-03: +35% vs S&P +4%OPBK 2020-06-15: -3% vs S&P +9%KYN 2026-02-24: +5% vs S&P +9%CBFV 2020-12-15: +13% vs S&P +8%CLDT 2020-08-24: +53% vs S&P +4%NWFL 2020-12-28: -1% vs S&P +7%PRKA 2023-08-21: -27% vs S&P +3%GCTK 2024-04-24: -40% vs S&P +10%DMLP 2021-04-27: +17% vs S&P +6%FAX 2025-09-30: -3% vs S&P +4%KTTA 2022-09-06: -14% vs S&P +3%FFIN 2021-12-02: -6% vs S&P -4%FBNC 2022-11-14: -8% vs S&P +4%ISTR 2022-03-02: +10% vs S&P -5%JUVF 2022-08-30: +2% vs S&P -0%ORI 2020-11-23: +15% vs S&P +10%CBKM 2021-06-25: +7% vs S&P +4%HBT 2023-03-15: +1% vs S&P +13%BWFG 2021-05-12: +14% vs S&P +10%GAM 2022-12-23: +3% vs S&P +3%EBF 2022-07-19: +1% vs S&P -6%ABR 2021-03-18: +14% vs S&P +8%SIGI 2026-02-03: -6% vs S&P +4%EVLV 2022-06-17: -30% vs S&P +7%MSPR 2022-09-15: -9% vs S&P +3%BWFG 2023-08-03: -12% vs S&P -6%MVBF 2025-12-08: -4% vs S&P -1%DAR 2022-05-25: -5% vs S&P +4%MCY 2025-12-11: -3% vs S&P -2%SMBK 2025-02-04: -13% vs S&P -6%PCB 2021-03-04: +11% vs S&P +12%PEO 2024-05-02: +6% vs S&P +9%DNP 2021-06-01: +6% vs S&P +8%JFR 2023-09-08: +1% vs S&P +3%RSG 2021-05-20: +10% vs S&P +6%FMCB 2021-09-20: +8% vs S&P +6%PEBO 2024-05-09: -3% vs S&P +0%BMACX 2025-11-13: +2% vs S&P +3%FINW 2025-11-03: -10% vs S&P +2%HROW 2021-07-22: +29% vs S&P +4%ISD 2023-12-07: +9% vs S&P +12%FCCO 2022-10-25: +16% vs S&P +5%ROCK 2021-11-23: -35% vs S&P -7%EWTX 2023-12-28: +56% vs S&P +10%BSVN 2022-05-25: +3% vs S&P +4%MLP 2025-09-11: -11% vs S&P +5%EBAY 2021-11-05: -24% vs S&P -4%FAST 2022-01-21: +3% vs S&P +0%ROAD 2023-01-11: -10% vs S&P +4%CSBR 2024-01-12: -27% vs S&P +9%CLFD 2022-08-31: +7% vs S&P +0%FRST 2023-08-14: +5% vs S&P -1%ACNB 2025-09-17: +17% vs S&P +3%IBCP 2026-02-27: -1% vs S&P +10%QNTO 2023-02-14: -22% vs S&P +0%PCG 2021-11-08: +4% vs S&P -4%IMKTA 2020-12-17: +48% vs S&P +7%INBK 2023-02-24: -55% vs S&P +5%HTLD 2022-09-09: +9% vs S&P -2%GNPX 2021-04-07: -21% vs S&P +7%PRGO 2025-05-14: -10% vs S&P +10%QNBC 2020-08-21: +8% vs S&P +6%PMN 2025-10-06: -48% vs S&P +2%APLE 2020-06-12: -9% vs S&P +10%HTD 2026-05-07: +1% vs S&P +5%DTIL 2025-09-30: -22% vs S&P +4%DNP 2021-10-05: +5% vs S&P +11%BBSI 2025-06-12: +10% vs S&P +8%COFS 2020-02-12: -5% vs S&P -15%CIZN 2023-02-06: -16% vs S&P +1%IBM 2024-11-13: +22% vs S&P +2%BZH 2020-12-08: +23% vs S&P +4%FDBC 2024-01-02: -19% vs S&P +11%NRT 2025-01-16: -16% vs S&P -11%CAPL 2024-02-02: +5% vs S&P +2%SFST 2026-03-09: +12% vs S&P +9%FRAF 2020-02-05: -33% vs S&P -14%PDX 2025-07-09: +1% vs S&P +8%ANDG 2026-05-22: +31% vs S&P +3%BFH 2025-08-01: +8% vs S&P +10%BLBD 2025-05-29: +49% vs S&P +10%PIIVX 2025-02-12: -4% vs S&P -2%NSP 2025-02-13: -18% vs S&P -3%BATRA 2025-03-18: +6% vs S&P +8%NCLH 2024-11-05: +7% vs S&P +4%ASIC 2026-05-05: +24% vs S&P +5%NKSH 2021-02-19: +8% vs S&P +7%ANNX 2026-03-12: -13% vs S&P +9%BBDC 2021-08-11: +6% vs S&P +6%ROG 2023-05-03: +2% vs S&P +12%OLB 2023-02-14: -13% vs S&P +0%JHS 2024-01-04: +2% vs S&P +12%CSBB 2021-08-04: +7% vs S&P +6%MAYS 2021-12-07: -2% vs S&P -10%SLNG 2021-04-12: +22% vs S&P +6%JKHY 2020-03-09: +19% vs S&P +17%ODC 2020-06-12: +11% vs S&P +10%BPRN 2024-06-10: +20% vs S&P +1%NBBK 2025-09-15: +14% vs S&P +3%SABR 2024-11-12: -4% vs S&P +2%GME 2023-03-31: +8% vs S&P +7%IPWR 2026-06-01: -36% vs S&P +2%CSBB 2024-11-18: +4% vs S&P +4%FRAF 2024-11-01: +4% vs S&P +6%ALZN 2022-08-23: +20% vs S&P -4%EAD 2020-12-23: +5% vs S&P +6%ITW 2024-12-11: -6% vs S&P -8%SBRA 2021-03-02: +4% vs S&P +9%ESQ 2021-02-05: +0% vs S&P +8%PDX 2024-12-09: -11% vs S&P -4%ARWR 2020-06-24: +10% vs S&P +9%NWBI 2026-01-29: +9% vs S&P +3%DK 2020-12-14: +59% vs S&P +9%GTIM 2021-03-31: +1% vs S&P +8%DAR 2021-05-21: +8% vs S&P +6%CODI 2020-06-25: +3% vs S&P +5%PFBX 2024-11-25: +8% vs S&P +1%HQL 2025-12-18: +2% vs S&P -2%SHBI 2021-08-12: +12% vs S&P +4%ECL 2023-06-15: -1% vs S&P +1%AAOI 2020-06-16: +11% vs S&P +9%BHB 2026-04-28: +13% vs S&P +4%This buy: result due Feb 7, 2027
Median vs. S&P 500-1.1%
Average vs. S&P 500+0.5%
Best+355.0%
Worst-73.1%

History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this

MTRI insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2026: $35K bought (1 trades)$35KQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$35K1—0

Valuation, profit and volume

Watchlist score 44/100
Market value$837MBiotechnology
Profit margin0.0% 
Volume vs. 50-day8.8×Last 5 sessions
Insiders' paper profit+$15KOn all tracked purchases +42.0%

Source: Yahoo Finance, as of Nov 11, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 InMed Pharmaceuticals Inc. insider reported open-market purchases totaling $35K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Adar1 Capital Management, LLC (10% Owner) has the highest Insider Score at 80.

MTRI stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after MTRI insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 9, 2026Adar1 Capital Management, LLC10% Owner$35K pendingpendingpending

Insiders at InMed Pharmaceuticals Inc.

InsiderBoughtSoldLast filingPast buys beat S&PScore
Adar1 Capital Management, LLC10% Owner $35K — Nov 9, 2026 1 of 1 80

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • MPLTMapLight Therapeutics, Inc.$50.1M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought
  • MDGLMADRIGAL PHARMACEUTICALS, INC.$35.0M bought

MTRI stock: common questions

Are InMed Pharmaceuticals Inc. insiders buying MTRI stock?

In the past 12 months, 1 insider reported open-market purchases of MTRI worth $35K. The latest was 10% Owner Adar1 Capital Management, Llc bought $35K of MTRI at $13.10 — first open-market purchase in our records.

Are InMed Pharmaceuticals Inc. insiders selling MTRI stock?

No. No InMed Pharmaceuticals Inc. insider reported an open-market sale of MTRI in the past 12 months.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is MTRI's 52-week range?

Over the past year MTRI has traded between $6.15 and $18.60. It last closed at $18.60 on Nov 13, 2026.